Paden brings to this position over 20 years of diverse experience in clinical research, including operational and scientific leadership roles, clinical trial management and monitoring, publication planning, product lifecycle management, and clinical training and education.
At Prometrika, Paden will lead clinical operations in day-to-day trial management activities and in the development of systems and procedures to further enhance the company's delivery of clinical research.
Paden's leadership roles have included head of clinical development operations at ContraFect Corp., senior consultant at Halloran Consulting, and director of clinical development medical affairs at Boehringer Ingelheim Pharmaceuticals.
Her work has covered orphan indications in oncology, cardiovascular disease, and genetic disorders.
Founded in 2003 and based in Cambridge, Massachusetts, Prometrika utilises a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team involved in all phases of trials.
Prometrika's services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign